tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
GL26 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
CRC, |
RKO |
|
|
|
AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,
tumCV↓, CSCs↓, selectivity↑, Apoptosis↑, ROS↑, LDH↓, Casp3↑, BAX↑, Bak↑, cMyc↑, MMP↓,
tumCV↓, DNAdam↑, MMP↓, ROS↑, TumCCA↑, TOP1↓,
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27/CDKN1B↑, P53↑,
| - |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, mTOR↓, Hif1a↓, selectivity↑, Dose↝, tumCV↓,
tumCV↓, TumCMig↓,
tumCV↓, Apoptosis↑, TumCCA↑, GRP78/BiP↑, GRP94↑, CEBPA↑, CHOP/DDIT3↑, Ca+2↑, Casp12↑, Casp9↑, Casp3↑, Cyt‑c↑, BAX↑, Bcl-2↓, ER Stress↑, MMP↓,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
WI38 |
|
|
|
tumCV↓, selectivity↑, Apoptosis↑, Casp8↑, Casp9↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Cerv, |
HTB-35 |
|
|
|
tumCV↓, TumCP↓, ADAM17↓, EGFR↓, p‑Akt↓, p‑ERK↓,
compI↓, compIII↓, ETC↓, ROS↑, Apoptosis↑, tumCV↓, selectivity↑, MMP↓, ATP↓, OXPHOS↓, ECAR↓, Glycolysis↓,
tumCV↓, ROS↑, eff↓, TumAuto↓,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
tumCV↓, GSH↓, MDA↑, ROS↑, Apoptosis↑,
eff↑, tumCV↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HaCaT |
|
|
|
DNAdam↑, Apoptosis↑, ChemoSen↑, ROS↑, mt-ROS↑, Casp↑, Casp3↑, selectivity↑, TumCP↓, tumCV↓, eff↓,
tumCV↓, TumAuto↑, Casp3↑, BAX↑, Beclin-1↑, ATG3↑, ATG5↑, Bcl-2↓, mTOR↓, PI3K↓, Akt↓, PTEN↑, ROS↑, MMP↓,
Apoptosis↑, cycD1/CCND1↓, Casp3↑, GRP78/BiP↑, CHOP/DDIT3↑, tumCV↓, IRE1↑, p‑PERK↑, c-ATF6↑, ER Stress↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
LLC1 |
|
|
|
eff↑, tumCV↓, ATP↓, ROS↑, Casp3↑, Casp7↑, mtDam↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
sarcoma, |
S180 |
|
|
|
tumCV↓, ROS↑, *GutMicro↑, BioAv↑, other↝, Dose↝,
| - |
in-vivo, |
Cerv, |
HeLa |
|
|
|
- |
in-vivo, |
Cerv, |
SiHa |
|
|
|
TumCG↓, toxicity↓, tumCV↓, Apoptosis↑, p‑PI3K↓, p‑Akt↓, eff↑,
eff↑, ROS↑, tumCV↓, TumCG↓, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, Bcl-xL↑, Cyt‑c↑, Bcl-2↓,
Showing Research Papers: 1 to 20 of 20
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 20
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
compI↓, 1, GSH↓, 1, MDA↑, 1, OXPHOS↓, 1, ROS↑, 11, mt-ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 2, BOK↑, 1, compIII↓, 1, ETC↓, 1, MMP↓, 5, mtDam↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, cMyc↑, 1, ECAR↓, 1, GlucoseCon↓, 1, Glycolysis↓, 2, lactateProd↓, 1, LDH↓, 1, PDK1↓, 1, PKM2↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, p‑Akt↓, 3, APAF1↑, 1, Apoptosis↑, 10, BAD↓, 1, Bak↑, 1, BAX↑, 4, Bcl-2↓, 4, Bcl-xL↑, 1, BID↑, 1, Casp↑, 2, Casp12↑, 1, Casp3↑, 7, cl‑Casp3↑, 1, Casp7↑, 2, Casp8↑, 2, Casp9↑, 3, cl‑Casp9↑, 1, Cyt‑c↑, 2, FADD↑, 1, Fas↑, 1, FasL↑, 1, Mcl-1↓, 1, NAIP↓, 1, p27/CDKN1B↑, 1, TRAIL↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1, tumCV↓, 20,
Protein Folding & ER Stress(tgid=8) ⓘ
c-ATF6↑, 1, CHOP/DDIT3↑, 2, ER Stress↑, 2, GRP78/BiP↑, 2, GRP94↑, 1, IRE1↑, 1, p‑PERK↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG3↑, 1, ATG5↑, 1, Beclin-1↑, 1, TumAuto↓, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 3, P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 2, cycE1↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CEBPA↑, 1, CSCs↓, 1, p‑ERK↓, 1, GSK‐3β↑, 1, mTOR↓, 3, PI3K↓, 1, p‑PI3K↓, 1, PTEN↑, 1, TOP1↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
Ca+2↑, 1, TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1, EPR↑, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
TNF-α↑, 1,
Cellular Microenvironment(tgid=17) ⓘ
ADAM17↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, ChemoSen↑, 1, Dose↝, 2, eff↓, 2, eff↑, 6, selectivity↑, 6,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, LDH↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, toxicity↓, 1,
Total Targets: 96
Pathway results for Effect on Normal Cells:
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1,
Total Targets: 1
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page